Xentria Meitheal The Innovative Solution for Community Transformation

Meitheal Pharmaceuticals Grows Specialty Biopharmaceuticals Portfolio with Exclusive Commercial Licensing Agreement for XENLETA® (lefamulin ... In addition, Victoria is the General Counsel & Corporate Secretary of Xentria, Inc. a biotech company focused on novel biologics and biosimilars, which was ... Tom Shea is the founding President of Xentria and the founding CEO of Meitheal Pharmaceutical, Inc. 01. Xentria · U.S.A arrow. Post Enquiry. Pharma, Lab & Chemical Expo. Not Confirmed. Xentria ... Xentria · U.S.A ... Meitheal Pharmaceuticals. Deal Size : $680.0 ... ... Meitheal's General Counsel & Corporate Secretary since its inception in 2017. In addition, Victoria is the Corporate Secretary of Xentria, Inc. a biotech ... Under the terms of the agreement, Meitheal gains the sole rights to sell and distribute XTMAB-16 in North America. Xentria retains the rights to ... 健友股份(603707)6月27日晚间公告，公司全资子公司香港健友（被许可方代表）及香港健友控股子公司Meitheal（被许可方）拟与Xentria签署许可协议，Xentria授予被许可方 ... Tom. Matthews is a former employee of Meitheal Pharmaceuticals, Inc. and a current employee of Xentria, Inc. Vivek B. Ajmani, Zhun Cao, Laura. L. Schott, and ... Xentria is a drug development company with ... In 2023, XTMAB-16 was exclusively licensed by Meitheal ... Founding President Tom Shea, MBA is also ... Targeted Delivery of ASO Gapmers to Muscle for the Treatment of Myotonic Dystrophy Type 1 · Xentria and Meitheal Collaborate on Breakthrough Lung ...